Datos Health: Feasibility, Safety, and Effectiveness of a Mobile Application Study Shows Datos’ TeleHealth Platform Improves Cardiac Rehab and Patient Adherence

June 30, 2020

Datos Health, a provider of hospital-grade automated remote care and telemedicine platforms, announced today the results of new research with Sheba Medical Center, showing that tele-cardiac rehabilitation (tele-CR) can improve adherence and exercise capacity among cardiac rehabilitation (CR) patients.

The clinical study, Feasibility, Safety, and Effectiveness of a Mobile Application in Cardiac Rehabilitation, published in the Israel Medical Association Journal (IMAJ), evaluated clinical and physiological outcomes, as well as patient adherence, to assess the viability of tele-CR as an alternative option to center-based rehabilitation. The six-month trial, performed with Sheba’s Cardiac Rehabilitation Center, is the first attempt to utilize digital health technology for remotely monitored cardiac rehabilitation.

“Despite the clear benefits of CR in reducing cardiac mortalities and improving the overall quality of life, it is often woefully underutilized for reasons including challenges in attending rehabilitation centers and interference with day-to-day life,” said Prof. Robert Klempfner, MD, Director of the Israeli Center for Cardiovascular Research and Scientific Director of the ARC Innovation Center at Sheba Medical Center. “The findings of this study reveal considerable advantages of tele-CR in the increase of adherence to exercise programs and improved patient outcomes.

The versatility of Datos’ remote care platform and its ability to increase patient engagement and adherence through personalization of the application is integral to making tele-CR a viable option for patients unable or unwilling to participate in center-based CR programs.”

Study results revealed significant improvement in exercise capacity and consistent adherence among patients, with over 63% completing the goal of 150 minutes of aerobic exercise per week. Overall patient satisfaction with the program was favorable, with a score of 4.05 out of 5. The success of the project resulted in the Israeli Ministry of Health defining a new reimbursement code for cardiac rehabilitation.

Patients received a smartphone application with a customized care plan, and monitoring devices that provided personalized feedback following each training session. Datos developed the application and accompanying care team dashboard to provide remote patient monitoring and continuity of care throughout the program. A dedicated care management portal provided care teams with information on patient adherence and progress.

“Remote care and telemedicine solutions are helping health systems to reduce costs and improve recovery through increased engagement between patients and their care teams outside of hospital settings,” said Uri Bettesh, CEO and Founder of Datos Heath. “As shown by the Ministry of Health’s actions, this can also effect positive regulatory change. However, success of such programs is dependent on developing strong partnerships between healthcare organizations and technology developers. Datos has enjoyed a long-standing relationship with Prof. Klempfner and his team at Sheba. This collaboration is further evidence of how together we can bring positive change to the provision of care for the benefit of large patient populations.”

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”
Exit mobile version